Search results for "Lung cancer"

MedicalMar 09, 2026

Frequent CT After Lung Cancer Surgery For Fear Of Recurrence?
ApparatusFeb 25, 2026

J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer
MedicalFeb 24, 2026

New Treatment For Lung Cancer Approved! Significantly Better Than Chemotherapy!
MedicalJan 31, 2026

K-Drug Approved For Adjuvant Treatment Of Early-Stage Non-Small Cell Lung Cancer, Significantly Extending Cancer-Free Survival Of Patients!
MedicalJan 30, 2026

Study Shows Drug Halves Recurrence Rate In Patients With Early-Stage EGFR-Mutated Lung Cancer!
ApparatusJan 29, 2026

Over 30% Of Tumours In Advanced Lung Cancer Patients In Remission With Frontier Drug Teliso-V In Combination With Troche!
MedicalDec 23, 2025

More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy!
ApparatusDec 19, 2025

Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For
DiseaseAug 07, 2023

J Thorac Oncol: Survival Differences In Lung Cancer Patients By Gender And The Impact Of Prognostic Factors On Them

ApparatusMar 11, 2026

Fda Accepts Zuranolone's Nda Application And Grants It Priority Review For The Treatment Of Mdd And Pdd

DiseaseSep 26, 2025

How Confirm The Diagnosis Of Highly Differentiated Cholangiocarcinoma With Lymph Node Metastasis? How To Treat Highly Differentiated Cholangiocarcinoma With Metastatic Lymph Nodes?

HealthyFeb 05, 2026

What Do Women Take To Nourish Their Blood When They Are Anemic?

HospitalMar 01, 2026

Heidelberg University Hospital

HealthyMar 06, 2026

How To Manage Dampness And Heat In The Spleen And Stomach

HospitalAug 07, 2023

Duke University Hospital

Search results for "Lung cancer"

World's 2nd KRAS Inhibitor Approved For Non-Small Cell Lung Cancer With 80% Efficacy!

Apparatus

Frequent CT After Lung Cancer Surgery For Fear Of Recurrence?

J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer

New Treatment For Lung Cancer Approved! Significantly Better Than Chemotherapy!

K-Drug Approved For Adjuvant Treatment Of Early-Stage Non-Small Cell Lung Cancer, Significantly Extending Cancer-Free Survival Of Patients!

Study Shows Drug Halves Recurrence Rate In Patients With Early-Stage EGFR-Mutated Lung Cancer!

Over 30% Of Tumours In Advanced Lung Cancer Patients In Remission With Frontier Drug Teliso-V In Combination With Troche!

More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy!

Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For

J Thorac Oncol: Survival Differences In Lung Cancer Patients By Gender And The Impact Of Prognostic Factors On Them

YOU MAY LIKE